Compare
Atrovent HFA vs. Combivent

Atrovent HFA (ipratropium) is a short-acting inhaled anticholinergic medication used to help with difficulty breathing in people with chronic obstructive pulmonary disease (COPD). This medication comes in an inhaler. Typically, you breathe in 2 inhalations, 4 times a day. You should use Atrovent HFA (ipratropium) regularly every day in order it for it to keep your COPD symptoms under control. It's not meant to be used as a rescue inhaler.

• Maintenance treatment of chronic obstructive pulmonary disease (COPD) in adults

• Cough and other symptoms of bronchitis (10-23%)
• Worsened COPD symptoms (8-23%)
• Trouble breathing (7-8%)
• Tiredness, chills, and other flu-like symptoms (4-8%)
• Headache (6-7%)
• Back pain (2-7%)

• Severe allergic reactions
• Narrowing of your airways (bronchospasm)
• Risk of eye and vision problems
• Trouble urinating

Combivent Respimat is an inhaler that's used to treat chronic obstructive pulmonary disease (COPD) in adults. It's a combination medication that contains two different bronchodilators: ipratropium, a short-acting muscarinic antagonist (SAMA), and albuterol, a short-acting beta agonist (SABA). The medication is inhaled through the mouth 4 times a day, but up to 6 times per day if instructed. Combivent Respimat (ipratropium / albuterol) isn't a rescue inhaler; it's used regularly rather than as needed for sudden breathing problems. Side effects aren't common but can include upper respiratory tract infections and cough.

• Maintenance treatment for chronic obstructive pulmonary disease (COPD) in adults who need more than one bronchodilator

• Common cold symptoms (4%)
• Upper respiratory infection (3%)
• Cough (3%)
• Bronchitis (3%)
• Headache (3%)

• Narrowing of the airways (bronchospasm)
• Effects on the heart and blood pressure
• Eye problems
• Trouble urinating
• Severe allergic reaction
• Low potassium in the blood